LungBlog

Lung cancer is the most fatal cancer and in India bidis contribute to chest tumor, said Dr Manjit Singh Bains, a US- based surgeon, while delivering a talk on necessity of treatment of early stage lung cancer, during the fourth day of 68th annual conference of Association of Surgeons of India. “In the US, lung cancer causes most cancer deaths in a year, but it is now on a decline as the rate of incidence had reduced from 40 per cent of all the cancer cases to 30 per cent,” he said.

A common food additive used to bulk out processed meats could fuel the spread of lung cancer.

Researchers found that high doses of inorganic phosphate salts – used to raise the water content of ham, bacon and chicken – can speed up the growth of tumours.

Susan M. Conrath, PhD, MPH, U.S. Public Health Service issued the following statement December 17, 2008 regarding radon health risk and smoking.

“EPA’s 2003 risk assessment, based on the National Academy of Science’s BEIR VI Report shows a risk of lung cancer deaths to be 6/100 for smokers and 7/1000 for never smokers. Since most federal agencies regulate substances which cause 1 death per million and occasionally 1 death per 100,000, the radon risks are huge.

Cancer will become world’s number one killer by 2010, as the number of people in poorer countries dying from the disease is expected to grow due to smoking, high-fat diets and other factors, the World Health Organization warned at the beginning of this month.

From all cancers, lung cancer appears to be a major reason of concern in the next years, as the number of people smoking is on the rise. It’s true that more people are trying to quit the habit but only few succeed.

Palm Beach Gardens, Fla. (PRWEB) December 15, 2008 — CyberKnife Center of Palm Beach, http://www.cyberknifepalmbeach.com, announced today that the first patient has been enrolled in the landmark study comparing traditional surgery and CyberKnife® radiosurgery treatment outcomes in early stage operable and resectable lung cancer.

The randomized, prospective clinical study, led by University of Texas M. D. Anderson Cancer Center in Houston, Texas, will evaluate the potential for radiosurgery as a non-invasive treatment alternative for operable lung cancer patients.

 Lung cancer has for the first time overtaken breast cancer to become the top killer of women Down Under, according to a report.

With the change in the society, women in Australia are enjoying same freedom as men and have largely picked up cigarette smoking.

According to the Australian Institute of Health and Welfare, the lung cancer rates are expected to increase by 0.4 per cent a year until 2010 for women and to drop by 1.1 per cent for men.

Cancer Council of Australia chief executive Professor Ian Olver said lung cancer had for the first time overtaken breast cancer as the largest killer of women.

It has been known for several years that inositol hexaphosphate (IP6) found in beans, legumes and some other vegetables exhibits potent anti-cancer action. Scientists have recently discovered an additional anti-cancer compound in legumes, known as inositol pentakisphosphate. In a study reported in Cancer Research, the newly discovered compound was tested in mouse models and on cancer cells. Not only was it found to inhibit the growth of tumors in mice independently, the phosphate also enhanced the effect of cytotoxic drugs in ovarian and lung cancer cells. This finding suggests that inositol pentakisphosphate could be used to sensitize cancer cells to the action of commonly used anti-cancer drugs.

Oncology Nursing News reports on December 08, 2008 that a clinical trial has begun at the Moores Cancer Center at the University of California, San Diego in La Jolla to test the effectiveness of a new vaccine for lung cancer.

The vaccine, called Lucanix (NovaRX Corporation, San Diego, Calif), is made from gene-modified tumor cells. If proved effective, it will not only help a patient’s immune system to fight off cancer, it will also make the cancer shut down its immune system-suppression activities.

Dr. David Vesely’s amazing hormones have returned from their world tour. In June in Shanghai, Vesely gave a keynote speech: “Cardiac Hormones for the Treatment of Cancer.” In September in Istanbul he gave another: “Novel Cardiovascular Hormones.” In October in Nuremberg: “Magic Bullets for the Treatment of Congestive Heart Failure, Renal Failure and Cancer.”

Two common polymorphisms in the 3′ untranslated regions of adenosine triphosphate-binding cassette B1 and C1 (ABCB1 and ABCC1) are linked to a greater risk of developing lung cancer, according to research published online Dec. 23 in Cancer.Haijian Wang, Ph.D., of Fudan University in Shanghai, China, and colleagues genotyped six common regulatory single-nucleotide polymorphisms of ABCB1 and ABCC1, using blood samples from 500 patients with lung cancer and 517 controls without lung cancer. ABCC1 has been shown to be involved in the elimination of metabolites of the tobacco carcinogen NNK, and ABCB1 removes harmful agents in the lungs.